Cellectar Biosciences, Inc. Insider Trading
CLRB
Insiders bought 50K and sold $733 on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. Director John Neis sold $733 on Dec 12, 2025, 95% of their stake, outside a plan.
Get an email when CLRB's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| May 7 | Jarrod Longcor Chief Operating Officer | Bought | 8,680 | $2.88 | 25K | 74% | Form 4 |
| May 7 | James V Caruso Chief Executive Officer | Bought | 8,680 | $2.88 | 25K | 75% | Form 4 |
| Dec 12, 2025 | John Neis Director | SoldNo plan | 198 | $3.70 | $733 | 95% | Form 4 |
| Jul 2, 2025 | James V Caruso Chief Executive Officer | Bought | 10,000 | $4.99 | 50K | 611% | Form 4 |
| Jul 2, 2025 | Jarrod Longcor Chief Operating Officer | Bought | 10,000 | $4.99 | 50K | 361% | Form 4 |
| Jul 2, 2025 | Chad J Kolean Chief Financial Officer | Bought | 5,000 | $4.99 | 25K | 353% | Form 4 |
| Jan 10, 2025 | Jarrod Longcor Chief Operating Officer | Bought | 30,000 | $0.28 | 8K | 56% | Form 4 |
- May 7Jarrod LongcorChief Operating Officer · bought 8,680 at $2.8825K74% of stake
- May 7James V CarusoChief Executive Officer · bought 8,680 at $2.8825K75% of stake
- Dec 12, 2025No planJohn NeisDirector · sold 198 at $3.70$73395% of stake
- Jul 2, 2025James V CarusoChief Executive Officer · bought 10,000 at $4.9950K611% of stake
- Jul 2, 2025Jarrod LongcorChief Operating Officer · bought 10,000 at $4.9950K361% of stake
- Jul 2, 2025Chad J KoleanChief Financial Officer · bought 5,000 at $4.9925K353% of stake
- Jan 10, 2025Jarrod LongcorChief Operating Officer · bought 30,000 at $0.288K56% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with CLRB
Spot a number that looks wrong? Check it in CLRB's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CLRB
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.